Literature DB >> 9162270

The rationing debate. Rationing within the NHS should be explicit. The case against.

J Coast1.   

Abstract

Mesh:

Year:  1997        PMID: 9162270      PMCID: PMC2126470          DOI: 10.1136/bmj.314.7087.1118

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  The impact of health economics on healthcare delivery: the health economists' perspective.

Authors:  R McDonald; A Haycox; T Walley
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

Authors:  David L B Schwappach
Journal:  Health Expect       Date:  2002-09       Impact factor: 3.377

3.  Should the Lambda (λ) Remain Silent?

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

4.  Deciding how NHS money is spent: a survey of general public and medical views.

Authors:  Ann Lees; Nicholas Scott; Sheila N Scott; Sara MacDonald; Christine Campbell
Journal:  Health Expect       Date:  2002-03       Impact factor: 3.377

5.  The prioritization preferences of pan-Canadian Oncology Drug Review members and the Canadian public: a stated-preferences comparison.

Authors:  C Skedgel
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

6.  Who wants to know if their care is rationed? Views of citizens and service informants.

Authors:  J Coast
Journal:  Health Expect       Date:  2001-12       Impact factor: 3.377

7.  Waiting in the NHS, part 2: a change of prescription.

Authors:  Sarah Derrett; Nancy Devlin; Anthony Harrison
Journal:  J R Soc Med       Date:  2002-06       Impact factor: 18.000

8.  Bedside rationing by general practitioners: a postal survey in the Danish public healthcare system.

Authors:  Sigurd M R Lauridsen; Michael Norup; Peter Rossel
Journal:  BMC Health Serv Res       Date:  2008-09-22       Impact factor: 2.655

9.  The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017.

Authors:  Chris Skedgel; Dominika Wranik; Min Hu
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.